Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled multicenter clinical trial was used to observe
the effectiveness, safety and side effects of Tianqi Pingzhan Granule in the prevention of
levodopa induced dyskinesia, so as to determine the clinical efficacy of Tianqi Pingzhan
Granule in the prevention of levodopa induced dyskinesia.
Phase:
N/A
Details
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators:
Huai'an First People's Hospital Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine Suqian Branch, Jiangsu Province Hospital Xin Hua Hospital of Zhejiang Province